Implementing a behavioural intervention for paediatric type 1 diabetes: Key informant perspectives of multilevel barriers and facilitators
Authors' conclusion
Study findings offer foundational knowledge on factors that influence implementation of evidence-based psychosocial type 1 diabetes care, which can be used to develop and test strategies to increase delivery of this care.
Study context
- Population
- Key informants on implementing a 4-session multiple family group Behavioral Family Systems Therapy for Diabetes (bBFST-D) for adolescents with T1D, 5 children's hospitals across the United Statessix key informant groups
- Participants
- 10 / 10 / 11 / 9 / 8 / 8
- Comparison
- Psychosocial professionals vs Medical professionals vs Clinical leaders vs Business leaders vs Adolescents vs Caregivers
- Psychosocial professionalsn = 10
- Medical professionalsn = 10
- Clinical leadersn = 11
- Business leadersn = 9
- Adolescentsn = 8
- Caregiversn = 8
- Outcome
- Perspectives on barriers and facilitators of implementing bBFST-D
Methodological detailsnational, multicentre, Consolidated Framework for Implementation Research 2.0, rapid analysis approach, Each participant completed a recorded, transcribed qualitative interview
- National
- Multicentre
- Consolidated Framework for Implementation Research 2.0
- Rapid analysis approach
- Each participant completed a recorded, transcribed qualitative interview
Main finding
As reported in the abstract
- All groups found bBFST-D content helpful and relevant
- All groups identified evidence that bBFST-D improves health outcomes as the most important implementation factor
- Healthcare leaders noted the influence of US News and World Report rankings
- Professionals highlighted buy-in from leadership, staffing, space and scheduling
- Caregivers and adolescents reported evening/weekend scheduling, referrals from trusted medical professionals and professional characteristics (empathetic, encouraging) as critical for engaging families
Original publication
Implementing a behavioural intervention for paediatric type 1 diabetes: Key informant perspectives of multilevel barriers and facilitators. Diabet Med. Published 20 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →